Advanced Nanoparticle-Based Labels for Lateral Flow Immunoassays
Lateral flow immunoassays (LFIAs) are among the most common tools used in point-of-care testing. However, conventional gold nanoparticle labels often lack the sensitivity needed to detect low-abundance biomarkers. To overcome this limitation, new nanomaterials have been developed to improve LFIA performance, but compar...